ELVN · Enliven Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Gupta Rishi Director | ▼ Sell | Open Market | 7,663,349 Shares held | 5/16/2024 | View profile |
| ORBIMED ADVISORS LLC Director | ▼ Sell | Open Market | 6,555,102 Shares held | 6/22/2026 | View profile |
| New Enterprise Associates 14, L.P. 10% Owner | ▼ Sell | Open Market | 2,611,050 Shares held | 4/6/2022 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Grant | 2,122,465 Shares held | 2/23/2023 | View profile |
| Braden Michael Leonard 10% Owner | ▼ Sell | Open Market | 1,767,774 Shares held | 1/4/2023 | View profile |
| COMMODORE CAPITAL LP 10% Owner | ▼ Sell | Other | 1,448,640 Shares held | 2/23/2023 | View profile |
| Andrew J. Schwab Director | ▲ Buy | Grant | 960,383 Shares held | 2/23/2023 | View profile |
| Kintz Samuel President and CEO | ▼ Sell | Open Market | 890,392 Shares held | 11/17/2025 | View profile |
| 5AM Partners VI, LLC 10% Owner | ▼ Sell | Open Market | 635,341 Shares held | 2/14/2024 | View profile |
| MOTT DAVID M Director | ▲ Buy | Open Market | 229,224 Shares held | 2/23/2022 | View profile |
| Jake Bauer Director | ▲ Buy | Grant | 87,372 Shares held | 2/23/2023 | View profile |
| Kunkel Lori Anne Director | ▼ Sell | Open Market | 41,884 Shares held | 7/6/2026 | View profile |
| Hohl Benjamin CHIEF FINANCIAL OFFICER | ▼ Sell | Open Market | 38,000 Shares held | 9/17/2026 | View profile |
| Attie Kenneth SVP, CMO | ▲ Buy | Grant | 34,100 Shares held | 1/28/2022 | View profile |
| GRAY MICHAEL CFO and COO | ▼ Sell | Open Market | 27,610 Shares held | 2/22/2023 | View profile |
| Collins Helen Louise CHIEF MEDICAL OFFICER | ▼ Sell | Open Market | 25,000 Shares held | 9/17/2026 | View profile |
| Heyman Richard A. Director | ▼ Sell | Open Market | 22,647 Shares held | 2/17/2026 | View profile |
| Ballal Rahul D. Director | ▼ Sell | Open Market | 22,341 Shares held | 10/8/2024 | View profile |
| Patel Anish Chief Operating Officer | ▲ Buy | Grant | 20,000 Shares held | 2/12/2026 | View profile |
| Lyssikatos Joseph P Chief Scientific Officer | ▲ Buy | Grant | 18,750 Shares held | 2/12/2026 | View profile |
| Derynck Mika K | ▼ Sell | Open Market | 0 Shares held | 8/4/2026 | View profile |
| Garland J. Scott | ▼ Sell | Open Market | 0 Shares held | 10/1/2026 | View profile |
Transaction History
| Garland J. Scott | ▲ Buy | Option Exercise | 13,000 | $201K | 10/1/2026 |
| Garland J. Scott | ▼ Sell | Open Market | 13,000 | $607K | 10/1/2026 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,982 | $59K | 9/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,535 | $177K | 9/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 2,194 | $111K | 9/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 289 | $15K | 9/17/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 5,000 | $12K | 9/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 2,916 | $146K | 9/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 1,844 | $94K | 9/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 240 | $12K | 9/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 4,630 | $270K | 8/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,388 | $82K | 8/17/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 5,000 | $12K | 8/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 3,900 | $228K | 8/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 1,100 | $65K | 8/17/2026 |
| Derynck Mika K | ▲ Buy | Option Exercise | 87,373 | $217K | 8/4/2026 |
| Derynck Mika K | ▲ Buy | Option Exercise | 27,567 | $697K | 8/4/2026 |
| Derynck Mika K | ▲ Buy | Option Exercise | 23,364 | $347K | 8/4/2026 |
| Derynck Mika K | ▲ Buy | Option Exercise | 20,491 | $460K | 8/4/2026 |
| Derynck Mika K | ▼ Sell | Open Market | 158,795 | $9.6M | 8/4/2026 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 1,072 | $3K | 7/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 324 | $16K | 7/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 369 | $19K | 7/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 2,564 | $134K | 7/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 2,638 | $141K | 7/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 123 | $7K | 7/17/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 5,000 | $12K | 7/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 231 | $12K | 7/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 459 | $24K | 7/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 2,063 | $108K | 7/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 2,184 | $117K | 7/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 63 | $3K | 7/17/2026 |
| Kunkel Lori Anne | ▼ Sell | Open Market | 4,111 | $205K | 7/6/2026 |
| Kunkel Lori Anne | ▼ Sell | Open Market | 5,889 | $299K | 7/6/2026 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 24,846 | $1.1M | 6/22/2026 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 1,477 | $66K | 6/22/2026 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 787,024 | $35.7M | 6/22/2026 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 46,776 | $2.1M | 6/22/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 1,133 | $51K | 6/17/2026 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 6,018 | $15K | 6/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,379 | $59K | 6/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,401 | $149K | 6/17/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,238 | $55K | 6/17/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 5,000 | $12K | 6/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 1,268 | $54K | 6/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 2,599 | $114K | 6/17/2026 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 9,086 | $409K | 6/15/2026 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 272,322 | $12.3M | 6/15/2026 |
| Kunkel Lori Anne | ▼ Sell | Open Market | 7,779 | $267K | 6/5/2026 |
| Kunkel Lori Anne | ▼ Sell | Open Market | 1,867 | $66K | 6/5/2026 |
| Kunkel Lori Anne | ▼ Sell | Open Market | 354 | $13K | 6/5/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 5,000 | $12K | 5/18/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 3,475 | $137K | 5/18/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 1,302 | $52K | 5/18/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 223 | $9K | 5/18/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 5,000 | $12K | 4/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 140 | $6K | 4/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 2,419 | $115K | 4/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 2,441 | $117K | 4/17/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 40,000 | $99K | 3/25/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 40,000 | $1.4M | 3/25/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 5,000 | $12K | 3/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 5,000 | $139K | 3/17/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 10,129 | $25K | 3/10/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 10,129 | $306K | 3/10/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 29,871 | $74K | 3/9/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 29,871 | $897K | 3/9/2026 |
| Hohl Benjamin | ▼ Sell | Open Market | 10,000 | $296K | 3/6/2026 |
| Heyman Richard A. | ▼ Sell | Open Market | 1,230 | $32K | 2/17/2026 |
| Collins Helen Louise | ▲ Buy | Option Exercise | 45,000 | $112K | 2/17/2026 |
| Collins Helen Louise | ▼ Sell | Open Market | 45,000 | $1.2M | 2/17/2026 |
| Collins Helen Louise | ▲ Buy | Grant | 25,000 | $0 | 2/12/2026 |
| Patel Anish | ▲ Buy | Grant | 20,000 | $0 | 2/12/2026 |
| Hohl Benjamin | ▲ Buy | Grant | 25,000 | $0 | 2/12/2026 |
| Lyssikatos Joseph P | ▲ Buy | Grant | 18,750 | $0 | 2/12/2026 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 5,000 | $145K | 2/6/2026 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 5,491 | $145K | 1/20/2026 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 14,509 | $390K | 1/20/2026 |
| Heyman Richard A. | ▼ Sell | Open Market | 512 | $14K | 1/20/2026 |
| Heyman Richard A. | ▼ Sell | Open Market | 718 | $19K | 1/20/2026 |
| Patel Anish | ▼ Sell | Open Market | 48,057 | $1.3M | 1/9/2026 |
| Patel Anish | ▼ Sell | Open Market | 243 | $7K | 1/9/2026 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 50,000 | $1.5M | 1/9/2026 |
| Heyman Richard A. | ▼ Sell | Open Market | 4,285 | $107K | 1/9/2026 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 41,198 | $1.0M | 1/9/2026 |
| Heyman Richard A. | ▼ Sell | Open Market | 1,620 | $41K | 1/8/2026 |
| Heyman Richard A. | ▼ Sell | Open Market | 8,015 | $201K | 1/8/2026 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 7,500 | $151K | 1/8/2026 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 33,802 | $842K | 1/8/2026 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 13,000 | $32K | 12/22/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 5,000 | $84K | 12/19/2025 |
| Kunkel Lori Anne | ▲ Buy | Option Exercise | 15,958 | $18K | 12/17/2025 |
| Patel Anish | ▼ Sell | Open Market | 4,958 | $103K | 12/8/2025 |
| Patel Anish | ▼ Sell | Open Market | 1,705 | $37K | 12/8/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 12,008 | $268K | 11/19/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 492 | $11K | 11/19/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 12,500 | $273K | 11/17/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,054 | $105K | 11/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 613 | $11K | 11/7/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 12,500 | $276K | 10/20/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 12,500 | $267K | 10/17/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,667 | $134K | 10/7/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 9/29/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,250 | $66K | 9/29/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 4,000 | $81K | 9/26/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 3,700 | $74K | 9/26/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 1,500 | $30K | 9/23/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 2,800 | $56K | 9/23/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 2,130 | $43K | 9/19/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 1,000 | $20K | 9/19/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 4,870 | $93K | 9/19/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 5,000 | $95K | 9/17/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,667 | $135K | 9/8/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 8/27/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,250 | $67K | 8/27/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 7,500 | $150K | 8/21/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 590 | $12K | 8/19/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 5,000 | $98K | 8/19/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 10,393 | $208K | 8/18/2025 |
| Patel Anish | ▼ Sell | Open Market | 405 | $8K | 8/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,262 | $114K | 8/7/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 7/28/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,185 | $65K | 7/28/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 65 | $1K | 7/28/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 11,924 | $265K | 7/21/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 576 | $13K | 7/21/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 4,150 | $90K | 7/17/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 4,687 | $106K | 7/17/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 3,663 | $86K | 7/17/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 1,000 | $2K | 7/10/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,000 | $23K | 7/10/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,362 | $126K | 7/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 305 | $6K | 7/7/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 6/27/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,052 | $64K | 6/27/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 198 | $4K | 6/27/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 12,500 | $267K | 6/20/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 10,502 | $232K | 6/17/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 1,998 | $45K | 6/17/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,000 | $7K | 6/13/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,000 | $68K | 6/13/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,607 | $134K | 6/9/2025 |
| Patel Anish | ▼ Sell | Open Market | 60 | $1K | 6/9/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 7,500 | $150K | 6/3/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 7,500 | $150K | 6/3/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,250 | $53K | 5/27/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 5/27/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 5,000 | $82K | 5/19/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 5,000 | $82K | 5/19/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,173 | $113K | 5/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 390 | $8K | 5/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 104 | $2K | 5/7/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 2,470 | $49K | 5/2/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 2,170 | $43K | 5/2/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 5,030 | $101K | 5/1/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 5,330 | $107K | 5/1/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 4/28/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,181 | $59K | 4/28/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 69 | $1K | 4/28/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 4,670 | $75K | 4/21/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 330 | $6K | 4/21/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 5,000 | $82K | 4/17/2025 |
| Patel Anish | ▼ Sell | Open Market | 3,756 | $67K | 4/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 2,763 | $51K | 4/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 148 | $3K | 4/7/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 3/27/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,250 | $69K | 3/27/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 1,000 | $2K | 3/24/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,000 | $23K | 3/24/2025 |
| Lyssikatos Joseph P | ▼ Sell | Open Market | 12,500 | $258K | 3/19/2025 |
| Kintz Samuel | ▼ Sell | Open Market | 12,500 | $260K | 3/17/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,667 | $143K | 3/7/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 10,000 | $25K | 3/4/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 2/27/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,250 | $66K | 2/27/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,667 | $146K | 2/7/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,000 | $23K | 2/5/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 1,000 | $2K | 2/5/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,250 | $8K | 1/27/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,250 | $70K | 1/27/2025 |
| Patel Anish | ▲ Buy | Option Exercise | 10,700 | $12K | 1/7/2025 |
| Patel Anish | ▲ Buy | Option Exercise | 2,000 | $5K | 1/7/2025 |
| Patel Anish | ▲ Buy | Option Exercise | 9,000 | $22K | 1/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 20,260 | $489K | 1/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 6,577 | $159K | 1/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 90 | $2K | 1/7/2025 |
| Patel Anish | ▼ Sell | Open Market | 1,440 | $35K | 1/7/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 1,000 | $2K | 1/3/2025 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,000 | $25K | 1/3/2025 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 900 | $2K | 12/30/2024 |
| Hohl Benjamin | ▼ Sell | Open Market | 900 | $20K | 12/30/2024 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 3,350 | $8K | 12/27/2024 |
| Hohl Benjamin | ▼ Sell | Open Market | 3,350 | $74K | 12/27/2024 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 13,000 | $32K | 12/13/2024 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 5,250 | $13K | 11/27/2024 |
| Hohl Benjamin | ▼ Sell | Open Market | 4,250 | $105K | 11/27/2024 |
| Hohl Benjamin | ▼ Sell | Open Market | 1,000 | $25K | 11/27/2024 |
| Hohl Benjamin | ▲ Buy | Option Exercise | 6,250 | $16K | 10/28/2024 |
| Hohl Benjamin | ▼ Sell | Open Market | 5,600 | $160K | 10/28/2024 |
| Hohl Benjamin | ▼ Sell | Open Market | 650 | $19K | 10/28/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Enliven's ENABLE-2 Trial Design Sparks New Questions
Enliven Therapeutics has clarified the design of its ENABLE-2 Phase 3 trial for relcobatinib in chronic myeloid leukemia, following questions raised by the trial’s structure. The company also confirmed FDA alignment on the study, while a separate patent dispute involving Halozyme and Merck has kept the leukemia treatment landscape in focus. These developments highlight the regulatory and strategic challenges Enliven faces as it moves toward clinical milestones.
Enliven's ENABLE-2 Trial Design Sparks New Questions. Enliven Therapeutics has clarified the design of its ENABLE-2 Phase 3 trial for relcobatinib in chronic myeloid leukemia, following questions raised by the trial’s structure. The company also confirmed FDA alignment on the study, while a separate patent dispute involving Halozyme and Merck has kept the leukemia treatment landscape in focus. These developments highlight the regulatory and strategic challenges Enliven faces as it moves toward clinical milestones.